Synthesis and inclusion study of a novel γ-cyclodextrin derivative as a potential thermo-sensitive carrier for doxorubicin

Chemical and Pharmaceutical Bulletin

Volumn 62, Issue 7, 2014, Pages 627-635

  Xu, Doudou ^a   Wang, Lijun ^a   Gourevich, Dana ^a   Kabha, Eihab ^b   Arditti, Fabian ^b   Athamna, Muhammad ^b   Cochran, Sandy ^a   Melzer, Andreas ^a   Gnaim, Jallal Muhammad ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b CapsuTech Ltd   (Israel)

Author keywords

Doxorubicin; Drug delivery system; pH stable; Thermo triggered; cyclodextrin

Indexed keywords

ALANINE; DOXORUBICIN; DRUG CARRIER; GAMMA CYCLODEXTRIN DERIVATIVE; NAPHTHALENE DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; GAMMA-CYCLODEXTRIN;

ACIDITY; ARTICLE; BINDING AFFINITY; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR OVERHAUSER EFFECT; PH; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROFLUOROMETRY; SYNTHESIS; TEMPERATURE; TEMPERATURE SENSITIVITY; THIN LAYER CHROMATOGRAPHY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; TOXICITY; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; DRUG STABILITY; GAMMA-CYCLODEXTRINS; HUMANS; HYDROGEN-ION CONCENTRATION; TEMPERATURE;

EID: 84904509921     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c13-00950     Document Type: Article

References (45)

1. Szejtli J., Cyclodextrin Technology, 1988, 79-306 (1988).
2. Allegre M., Deratani A., Agro. Food Industry Hi-Tech, 31, 9-17 (1994).
3. Uekama K., Hirayama F., Irie T., Chem. Rev., 98, 2045-2076 (1998).
4. Uekama K., Chem. Pharm. Bull., 52, 900-915 (2004).
5. Grosse P. Y., Bressolle F., Rouanet P., Joulia J. M., Pinguet F., Int. J. Pharm., 180, 215-223 (1999).
6. Fujiwara A., Hoshino T., Westley J. W., Critical Reviews in Biotechnology, 3, 133-157 (1985).
7. Fernandez A.-M., Van Derpoorten K., Dasnois L., Lebtahi K., Dubois V., Lobl T. J., Gangwar S., Oliyai C., Lewis E. R., Shochat D., Trouet A., J. Med. Chem., 44, 3750-3753 (2001).
8. Bekers O., Beijnen J. H., Otagiri M., Bult A., Underberg W. J. M., J. Pharm. Biomed. Anal., 8, 671-674 (1990).
9. Muggia F. M., Green M. D., Crit. Rev. Oncol. Hematol., 11, 43-64 (1991).
10. Forssen E., Willis M., Adv. Drug Deliv. Rev., 29, 249-271 (1998).
11. Lukyanov A. N., Elbayoumi T. A., Chakilam A. R., Torchilin V. P., J. Control. Release, 100, 135-144 (2004).
12. Low P. S., Antony A. C., Adv. Drug Deliv. Rev., 56, 1055-1058 (2004).
13. Soppimath K. S., Tan D. C. W., Yang Y. Y., Adv. Mater., 17, 318-323 (2005).
14. Liu S.-Q., Wiradharma N., Gao S.-J., Tong Y. W., Yang Y.-Y., Biomaterials, 28, 1423-1433 (2007).
15. Li Y. Y., Zhang X. Z., Kim G. C., Cheng H., Cheng S. X., Zhuo R. X., Small, 2, 917-923 (2006).
16. Králová J., Kejík Z., Břza T., Poućková P., Král A., Martásek P., Král V. J. Med. Chem., 53, 128-138 (2010).
17. Hattori K., Kenmoku A., Mizuguchi T., Ikeda D., Mizuno M., Inazu T., Journal of Inclusion Phenomena and Macrocyclic Chemistry, 56, 9-16 (2006).
18. Li L., Zhao M., Li W., Wang Y., Zhang Z., An R., Peng S., MedChemComm, 3, 1059-1061 (2012).
19. Yamanoi T., Yoshida N., Oda Y., Akaike E., Tsutsumida M., Kobayashi N., Osumi K., Yamamoto K., Fujita K., Takahashi K., Hattori K., Bioorg. Med. Chem. Lett., 15, 1009-1013 (2005).
20. Yamanoi T., Kobayashi N., Takahashi K., Hattori K., Letters in Drug Design & Discovery, 3, 188-191 (2006).
21. Oda Y., Kobayashi N., Yamanoi T., Katsuraya K., Takahashi K., Hattori K., Med. Chem., 4, 244-255 (2008).
22. Oda Y., Yanagisawa H., Maruyama M., Hattori K., Yamanoi T., Bioorg. Med. Chem., 16, 8830-8840 (2008).
23. Oda Y., Miura M., Hattori K., Yamanoi T., Chem. Pharm. Bull., 57, 74-78 (2009).
24. Sorokin A. V., Fylymonova I. I., Yefimova S. L., Malyukin Y. V., Optical Materials, 34, 2091-2094 (2012).
25. Tötterman A. M., Schipper N. G., Thompson D. O., Mannermaa J. P., J. Pharm. Pharmacol., 49, 43-48 (1997).
26. Gourevich D., Dogadkin O., Volovick A., Wang L., Gnaim J., Cochran S., Melzer A., J. Controlled Release, 170, 316-324 (2013).
27. Yamamura H., Yamada S., Kohno K., Okuda N., Araki S., Kobayashi K., Katakai R., Kano K., Kawai M., J. Chem. Soc., Perkin Trans. 1, 1999, 2943-2948 (1999).
28. Dai X., Yue Z., Eccleston M. E., Swartling J., Slater N. K., Kaminski C. F., Nanomedicine, 4, 49-56 (2008).
29. Karukstis K. K., Thompson E. H. Z., Whiles J. A., Rosenfeld R. J., Biophys. Chem., 73, 249-263 (1998).
30. Mohan C., Calbiochem, 2003, 18-23 (2003).
31. Tuszynski G. P., Murphy A., Anal. Biochem., 184, 189-191 (1990).
32. Emara S., Morita I., Tamura K., Razee S., Masujima T., Mohamed H. A., El-Gizawy S. M., El-Rabbat N. A., Talanta, 51, 359-364 (2000).
33. Swiech O., Mieczkowska A., Chmurski K., Bilewicz R., J. Phys. Chem. B, 116, 1765-1771 (2012).
34. Lee S. K., Okura I., Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 54, 91-100 (1998).
35. Schneider H. J., Hacket F., Rudiger V., Ikeda H., Chem. Rev., 98, 1755-1786 (1998).
36. Wang Y., Wang R., Lu X., Lu W., Zhang C., Liang W., Pharm. Res., 27, 361-370 (2010).
37. Singh R., Bharti N., Madan J., Hiremath S. N., J. Pharm. Sci. Technol., 2, 171-183 (2010).
38. Agrawal P., Barthwal S. K., Barthwal R., Eur. J. Med. Chem., 44, 1437-1451 (2009).
39. Anand R., Ottani S., Manoli F., Manet I., Monti S., RSC Advances, 2, 2346-2357 (2012).
40. Wagner B. D., Fitzpatrick S. J., McManus G. J., Journal of Inclusion Phenomena and Macrocyclic Chemistry, 47, 187-192 (2003).
41. Park J. W., "Cyclodextrin Materials Photochemistry, Photophysics and Photobiology, Chapter 1," Douhal A, Vol. 1, Elsevier, Amsterdam, 2006, pp. 1-26.
42. Schmaljohann D., Adv. Drug Deliv. Rev., 58, 1655-1670 (2006).
43. Tabushi I., Kiyosuke Y., Sugimoto T., Yamamura K., J. Am. Chem. Soc., 100, 916-919 (1978).
44. Chen Y., Xu T., Shen X., Gao H., Journal of Photochemistry and Photobiology A: Chemistry, 173, 42-50 (2005).
45. May J. P., Li S.-D., Expert Opin. Drug Deliv., 10, 511-527 (2013).